Emerging cell cycle inhibitors for treating metastatic castration-resistant prostate cancer.
"Review of the current literature identified cell cycle inhibitors under study in early phase clinical trials targeting the G1 (palbociclib, ribociclib, AZD-5363, ipatasertib), S (M-6620, prexasertib), G2 (adavosertib) and M (alisertib) phases of the cell cycle."
G1, S.
"Review of the current literature identified cell cycle inhibitors under study in early phase clinical trials targeting the G1 (palbociclib, ribociclib, AZD-5363, ipatasertib), S (M-6620, prexasertib), G2 (adavosertib) and M (alisertib) phases of the cell cycle."
G1, S.